PAPER Yang R, Meng X, Zhao W, Xu SQ, Wang SY, Li MM, Guan W, Chen QS, Zhang LL, Kuang HX, Li H, Yang BY, Liu Y
SEARCH RESULTS
4960 RESULTS
PAPER Tora V, Torok J, Bertsch M, Raj A
A network-level transport model of tau progression in the Alzheimer's brain.
Math Med Biol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.PAPER Aydın Ş, Özdemir S, Adıgüzel A
The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases.
J Mol Neurosci. 2025 Mar 13;75(1):34. PubMed.PAPER Silva-Llanes I, Rodríguez-López S, González-Naranjo P, Sastre ED, López MG, Páez JA, Campillo N, Lastres-Becker I
Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.
Brain Behav Immun. 2025 Mar 11;127:251-268. Epub 2025 Mar 11 PubMed.PAPER Chen Z, Lu Y, Wang Y, Wang Q, Yu L, Liu J
Natural Products Targeting Tau Protein Phosphorylation: A Promising Therapeutic Avenue for Alzheimer's Disease.
Planta Med. 2025 Mar 14; Epub 2025 Mar 14 PubMed.PAPER Inan S, Wilson RP, Tükel Ç
IUPHAR review: From gut to brain: The role of gut dysbiosis, bacterial amyloids, and metabolic disease in Alzheimer's disease.
Pharmacol Res. 2025 Mar 12;215:107693. Epub 2025 Mar 12 PubMed.PAPER Stein-O'Brien GL, Palaganas R, Meyer EM, Redding-Ochoa J, Pletnikova O, Guo H, Bell WR, Troncoso JC, Huganir RL, Morris M
Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer's disease.
Cell Rep. 2025 Mar 25;44(3):115422. Epub 2025 Mar 13 PubMed.PAPER Lin CH, Yang S, Huang YJ, Lane HY
Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.
Sci Rep. 2019 Dec 11;9(1):18840. PubMed.PAPER Hellwege JN, Keaton JM, Giri A, Gao X, Velez Edwards DR, Edwards TL
Population Stratification in Genetic Association Studies.
Curr Protoc Hum Genet. 2017 Oct 18;95:1.22.1-1.22.23. PubMed.Joseph Therriault, Yi-Ting Wang on Confirmed: Women Accumulate Tangles Faster Than Do Men
COMMENT Previous cross-sectional studies have indicated higher tau deposition in women, but there has been limited evidence from longitudinal studies suggesting females exhibit faster tau accumulation on average (Smith et al., 2020; Wang et al., 2024). This large
ASCB/EMBO Meeting: CELL BIO 25
CONFERENCE 2025-12-06 00:00:00-2025-12-10 00:00:00 Philadelphia, Pennsylvania 06 – 10 December 2025 View Conference Website 0
Marco Colonna on After Immunotherapy, Amyloid Clearance Comes Down to Microglial Moods
COMMENT This exciting study explores the role of microglia in immune-mediated clearing of Aβ plaques in AD. The study integrated spatial transcriptomics, proteogenomics, and scRNA-Seq to analyze postmortem brain tissues from AD patients who received active or pas
Giulia Albertini, Bart De Strooper on After Immunotherapy, Amyloid Clearance Comes Down to Microglial Moods
COMMENT In an era where anti-Aβ therapies are transitioning into widespread clinical practice, research into elucidating their working mechanisms, as well as their side effects, is crucial. Lynn van Olst, David Gate, and colleagues present a beautifully executed
PAPER Albertini A, Zielonka M, Cuypers ML, van Lieshout V, Snellinx A, Pasciuto E, Wolfs L, Craessaerts K, Horré K, Jaspers T, Fiers M, Dewilde M, De Strooper B
Using anti‐Aβ antibodies to modulate the multi‐pronged human microglia response to Aβ pathology
Alzheimers Dement. 2025 Jan 3 . Alzheimers & DementiaCynthia Lemere on After Immunotherapy, Amyloid Clearance Comes Down to Microglial Moods
COMMENT These studies allow an initial glimpse into the microglial response and Aβ removal following active Aβ vaccination and passive AŴ immunization. The following caveats should be kept in mind: AN1792 patients were immunized with full-length Aβ1-42 and a stro
Current Filters
- Date Range : Dec 2024 to Mar 2025 x